Filter Results:
(4,674)
Show Results For
- All HBS Web
(4,674)
- People (16)
- News (1,856)
- Research (2,242)
- Events (2)
- Multimedia (213)
- Faculty Publications (1,821)
Show Results For
- All HBS Web
(4,674)
- People (16)
- News (1,856)
- Research (2,242)
- Events (2)
- Multimedia (213)
- Faculty Publications (1,821)
- 04 Nov 2016
- News
New war on drugs: Pharma becoming 'uninvestable'?
- 01 Mar 2010
- News
Spin Cycle
Courtesy Cycle For Survival In 2004 at age 33, Jennifer Goodman Linn (MBA ’99) was diagnosed with MFH sarcoma, a rare soft-tissue cancer. Through 26 months of chemotherapy and four surgeries, Linn kept up her fitness, mainly through indoor stationary biking, or... View Details
- 02 Aug 2011
- News
A Fearless Force for Change
Jennifer Goodman Linn (MBA '99) left a legacy of hope to patients who battle rare cancers. Jennifer Goodman Linn (MBA '99) left a legacy of hope, love, and laughter to those who knew her and to the thousands who have been and will continue to be touched by Cycle for... View Details
- Profile
Inessa Lurye
MBA/MPP degree at HBS and Harvard Kennedy School, Inessa helped expand the reach of the HBS Design Club, and fulfilled a field project at Harvard Art Museums that developed art workshops designed around specific group interests. One thing her work never touched upon... View Details
- July 2014 (Revised January 2017)
- Course Overview Note
Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Spring 2016 class Building Life Science Businesses.7 View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Health Industry; Health Industry; Asia; North America; Europe
Hamermesh, Richard G. "Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus." Harvard Business School Course Overview Note 815-003, July 2014. (Revised January 2017.)
- February 2013
- Supplement
Cincinnati Children's Hospital Medical Center, Video Supplement 2012
By: Anita Tucker and Amy Edmondson
Keywords: Process Improvement; Leadership Succession; Healthcare; Quality And Safety; Transparency; Organizational Change and Adaptation; Management Succession; Health Care and Treatment; Performance Improvement; Business Processes; Health Industry; Ohio
Tucker, Anita, and Amy Edmondson. "Cincinnati Children's Hospital Medical Center, Video Supplement 2012." Harvard Business School Video Supplement 613-710, February 2013.
- January 1983 (Revised February 1988)
- Case
Hospital Corp. of America (A)
By: W. Carl Kester
HCAs ratio of debt to total capital is approaching 70%, jeopardizing its single-A bond rating. Students must determine an appropriate target debt ratio for HCA in light of its growth objectives, its acquisition strategy and its changing regulatory environment. View Details
Keywords: Situation or Environment; Capital Structure; Health Care and Treatment; Borrowing and Debt; Health Industry; Tennessee
Kester, W. Carl. "Hospital Corp. of America (A)." Harvard Business School Case 283-053, January 1983. (Revised February 1988.)
- June 2014
- Article
Informal Peer Interaction and Practice Type as Predictors of Physician Performance on Maintenance of Certification Examinations
By: Melissa A. Valentine, S. Barsade, Amy C. Edmondson, A. Gal and R. Rhodes
Context: Physicians can demonstrate mastery of the knowledge that supports continued clinical competence by passing a Maintenance of Certification exam. Exam performance depends on professional learning and development, which may be enhanced by informal routine... View Details
Keywords: Training; Health Care and Treatment; Performance; Social and Collaborative Networks; Learning; Health Industry
Valentine, Melissa A., S. Barsade, Amy C. Edmondson, A. Gal, and R. Rhodes. "Informal Peer Interaction and Practice Type as Predictors of Physician Performance on Maintenance of Certification Examinations." JAMA Surgery 149, no. 6 (June 2014): 597–603.
- 01 Jun 2020
- Working Paper Summaries
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
- March 2015 (Revised December 2016)
- Case
Philips Healthcare Latin America
By: Sunil Gupta
On a beautiful sunny afternoon in October 2013, Daniel Mazon (GMP 15), decided to take some time out of his busy schedule of the General Management Program (GMP) at the Harvard Business School to reflect on his company's situation. Mazon was the Vice President and... View Details
Keywords: Healthcare; Latin America; Organizational Structure; Salesforce Management; Health Care and Treatment; Health Industry; Health Industry; Latin America
Gupta, Sunil. "Philips Healthcare Latin America." Harvard Business School Case 515-097, March 2015. (Revised December 2016.)
Paris Wallace
School. In 2021 Paris sold Ovia Health to Labcorp (LH). Paris was the CEO and founder of Ovia Health, the leading women’s health and technology company. Ovia Health's fertility, pregnancy, and parenting... View Details
- 01 Jun 2009
- News
Alumni Books
mistakes. Managing Health Care Business Strategy by George B. Moseley III (MBA ’65) (Jones & Bartlett) This textbook examines strategic planning and management in the special environment of health-care... View Details
- 26 Apr 2023
- Cold Call Podcast
How Martine Rothblatt Started a Company to Save Her Daughter
- Web
FAQs - Institute For Strategy And Competitiveness
Health Delivery Project The Institute for Cancer Care Innovation MOC Network ICIC U.S. Cluster Mapping Project U.S. Competitiveness Project FSG Shared Value Initiative Social Progress Imperative AllWorld... View Details
- February 2022
- Case
Leading The UK Vaccine Task Force
By: Amy C. Edmondson and Claudia Pienica
This case describes the first six months of the UK Vaccine Taskforce, under the leadership of Kate Bingham. With a career spent in the private sector as a biotech investor, Bingham’s appointment within the government was considered unusual. The overarching brief given... View Details
Keywords: COVID-19; Vaccine; Government; Health Pandemics; Health Care and Treatment; Science; Innovation and Invention; Groups and Teams; Leadership; Decision Making; Government and Politics; Health; Innovation and Management; Governance; Change; Government Administration; Health Industry; Health Industry; Health Industry; Europe; United Kingdom
Edmondson, Amy C., and Claudia Pienica. "Leading The UK Vaccine Task Force." Harvard Business School Case 622-079, February 2022.
- August 2013 (Revised October 2013)
- Case
MedImmune Ventures
By: Richard G. Hamermesh and David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details
Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London
Hamermesh, Richard G., and David Lane. "MedImmune Ventures." Harvard Business School Case 814-023, August 2013. (Revised October 2013.)
- December 2005 (Revised April 2010)
- Teaching Note
Leerink Swann & Co.: Creating Competitive Advantage (TN)
By: Boris Groysberg and Andrew N. McLean
- August 2022
- Supplement
NOW PT (B): Should We Invest?
By: George A. Riedel, Amy Klopfenstein and Mel Martin
This (B) case examines the results of the HBS Impact Investment Fund student team’s diligence on Neurologic Optimal Wellness Physical Therapy (NOW PT). After examining Springfield’s demographics, anticipated PT demand, local competition, and NOW PT’s financial... View Details
Keywords: Entrepreneurship; Social Entrepreneurship; Finance; Investment; Health; Health Care and Treatment; Medical Specialties; Buildings and Facilities; Health Industry; Health Industry; North and Central America; United States; Massachusetts
Riedel, George A., Amy Klopfenstein, and Mel Martin. "NOW PT (B): Should We Invest?" Harvard Business School Supplement 323-014, August 2022.
- 2002
- Chapter
Cross Sector Collaboration: Lessons from the International Trachoma Initiative
By: Diana Barrett, James E. Austin and Sheila McCarthy
Keywords: Health Disorders; Health Care and Treatment; Public Sector; Private Sector; Business and Government Relations; International Relations; Health Industry
Barrett, Diana, James E. Austin, and Sheila McCarthy. "Cross Sector Collaboration: Lessons from the International Trachoma Initiative." In Public-Private Partnerships for Public Health, edited by Michael R. Reich.Harvard Series on Population and International Health. Harvard University Press, 2002.
- March 2015 (Revised September 2016)
- Case
Terrapin Laboratory
By: Richard G. Hamermesh and Joseph B. Fuller
Describes the formation and rapid growth of a drug testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. The associated teaching materials provide students the opportunity... View Details
Keywords: Business Growth; Entrepreneurial Management; Entrepreneurship; Growth Strategy; Market Entry; Venture Capital; Growth Management; Expansion; Financing and Loans; Health Care and Treatment; Health Testing and Trials; Business Startups; Health Industry; Health Industry
Hamermesh, Richard G., and Joseph B. Fuller. "Terrapin Laboratory." Harvard Business School Case 315-098, March 2015. (Revised September 2016.)